Kimie Sai Selected Research

Kimie Sai Research Topics

Disease

23	Neoplasms (Cancer) 02/2019 - 05/2002
6	Neutropenia 01/2013 - 07/2007
4	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2020 - 01/2011
3	Infections 01/2020 - 01/2017
3	Chemical and Drug Induced Liver Injury 01/2020 - 01/2012
3	Stomach Neoplasms (Stomach Cancer) 10/2015 - 01/2012
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021 - 01/2018
2	Drug-Related Side Effects and Adverse Reactions 12/2017 - 01/2017
2	Rhabdomyolysis 12/2017 - 01/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2017 - 01/2011
2	Diarrhea 01/2014 - 08/2008
2	Common Cold 01/2012 - 01/2011
1	Rheumatoid Arthritis 05/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2022
1	Cicatrix (Scar) 01/2021
1	Dysuria 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Necrosis 01/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2018
1	Communicable Diseases (Infectious Diseases) 12/2017
1	Hypocalcemia 01/2017
1	Muscular Diseases (Myopathy) 12/2016
1	Lactic Acidosis 06/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Hand-Foot Syndrome 01/2012
1	Acute-Phase Reaction 10/2011
1	Hyperlipidemias (Hyperlipidemia) 01/2011
1	Anaphylaxis (Anaphylactic Shock) 01/2011
1	Esophageal Squamous Cell Carcinoma 11/2010
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2010
1	Hepatocellular Carcinoma (Hepatoma) 11/2010
1	Lung Neoplasms (Lung Cancer) 11/2010
1	Hepatomegaly 04/2009

Drug/Important Bio-Agent (IBA)

15	Irinotecan (Camptosar)FDA LinkGeneric 01/2014 - 05/2002
10	Pharmaceutical PreparationsIBA 01/2021 - 05/2010
2	insulin receptor-related receptor (IRR)IBA 01/2021 - 01/2018
2	AntipyreticsIBA 01/2020 - 01/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2011
2	Denosumab FDA Link 02/2019 - 01/2017
2	ProdrugsIBA 01/2012 - 05/2002
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2012 - 01/2011
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 10/2011 - 11/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 08/2008
2	UGT1A1 enzymeIBA 08/2010 - 03/2008
2	7-ethyl-10-hydroxycamptothecin beta-glucuronideIBA 10/2007 - 06/2004
2	GlucuronidesIBA 07/2007 - 06/2004
2	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 04/2005 - 01/2003
1	Biosimilar PharmaceuticalsIBA 05/2022
1	HLA-B Antigens (HLA-B)IBA 01/2021
1	Tadalafil (Cialis)FDA Link 01/2021
1	Allopurinol (Remid)FDA LinkGeneric 01/2021
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021
1	asenapine FDA Link 01/2021
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	Zoledronic Acid (Zometa)FDA Link 01/2017
1	RANK LigandIBA 01/2017
1	HLA-DRB1*04 antigenIBA 12/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2016
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 10/2015
1	EnzymesIBA 10/2015
1	Tyrosine Kinase InhibitorsIBA 10/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2015
1	Metformin (Glucophage)FDA LinkGeneric 06/2015
1	PotassiumIBA 01/2014
1	LipidsIBA 01/2013
1	Carcinoembryonic AntigenIBA 01/2012
1	AntigensIBA 01/2012
1	Fluorouracil (Carac)FDA LinkGeneric 01/2012
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2012
1	Tumor Biomarkers (Tumor Markers)IBA 01/2012
1	Capecitabine (Xeloda)FDA Link 01/2012
1	CarbohydratesIBA 01/2012
1	Glycoproteins (Glycoprotein)IBA 10/2011
1	Orosomucoid (Seromucoid)IBA 10/2011
1	Carrier Proteins (Binding Protein)IBA 10/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011
1	EstersIBA 11/2010
1	Leucine (L-Leucine)FDA Link 11/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2010
1	Carboxylesterase (Hydrolase S)IBA 08/2010
1	Cisplatin (Platino)FDA LinkGeneric 05/2010
1	Peroxisome ProliferatorsIBA 04/2009
1	CarcinogensIBA 04/2009
1	perfluorooctanoic acidIBA 04/2009
1	Cytochrome P-450 CYP3AIBA 08/2008
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 04/2008
1	phosphatidylcholine-specific phospholipase CIBA 04/2008
1	SmokeIBA 04/2008
1	BilirubinIBA 06/2004

Therapy/Procedure

6	Therapeutics 01/2012 - 04/2008
2	Drug Therapy (Chemotherapy) 10/2015 - 01/2014
2	Combination Drug Therapy (Combination Chemotherapy) 12/2013 - 07/2007
1	Time-to-Treatment 01/2012